FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 56 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $488 | +48700.0% | 65 | -11.0% | 0.00% | – |
Q2 2023 | $1 | -99.5% | 73 | -99.7% | 0.00% | – |
Q1 2023 | $204 | – | 25,400 | +41539.3% | 0.00% | – |
Q2 2022 | $0 | – | 61 | -14.1% | 0.00% | – |
Q1 2022 | $0 | – | 71 | +31.5% | 0.00% | – |
Q4 2021 | $0 | – | 54 | +134.8% | 0.00% | – |
Q3 2021 | $0 | – | 23 | -58.2% | 0.00% | – |
Q2 2021 | $0 | – | 55 | +266.7% | 0.00% | – |
Q1 2021 | $0 | – | 15 | -80.8% | 0.00% | – |
Q3 2020 | $0 | – | 78 | +239.1% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 23 | -93.3% | 0.00% | – |
Q4 2019 | $2,000 | – | 342 | +159.1% | 0.00% | – |
Q3 2019 | $0 | – | 132 | -10.8% | 0.00% | – |
Q2 2019 | $0 | – | 148 | +410.3% | 0.00% | – |
Q1 2019 | $0 | – | 29 | +141.7% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 12 | -84.4% | 0.00% | – |
Q3 2018 | $1,000 | – | 77 | +234.8% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 23 | -59.6% | 0.00% | – |
Q4 2017 | $1,000 | – | 57 | +850.0% | 0.00% | – |
Q3 2017 | $0 | – | 6 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |